Stabilization of peroxidase

ABSTRACT

New and useful stable peroxidase compositions are disclosed which are particularly useful as reagents in enzyme immunoassay (EIA) tests. The novel peroxidase compositions contain polyvalent ions of groups 3 and 4 of the Periodic Table. These novel compositions are stable even in low peroxidase concentrations, and are relatively invulnerable to freeze-drying. Preferably, the polyvalent ions selected are those of Al, Zn, Mg, Fe, and Cu.

This application is a continuation of application Ser. No. 006,934, filed Jan. 25, 1979, now U.S. Pat. No. 4,228,240, which in turn is a continuation of application Ser. No. 831,817, filed Sept. 9, 1977, now U.S. Pat. No. 4,169,012.

BACKGROUND TO THE INVENTION

1. Field of the Invention

The invention relates to a method for the stabilization of compositions containing peroxidase.

It is known that peroxidases, whether or not coupled to another component, are not very stable, particularly in low concentrations, and that their keeping qualities are therefore poor.

It has furthermore been shown that compositions containing peroxidases are very sensitive and vulnerable to freeze-drying.

Peroxidases are enzymes which catalyse the oxidation of certain compounds, during which oxidation a peroxide, and in particular hydrogen peroxide, functions as donor. They may be obtained from plants, for example horse radish peroxidase, from vertebrate animals, for example tryptophan pyrrolase, and from micro-organisms, such as cytochrome c peroxidase from Pseudomonas.

Peroxidases are used for very diverse purposes, including their use as reagents in diagnostic determinations, e.g. as a reagent in the glucose oxidase method for determining glucose, and their importance has increased even more since the development of the so-called enzyme immunotest, and immunological method of estimation for the demonstration of haptens, antigens and antibodies in which an immunological component, for example an antigen, coupled to an enzyme is used as a reagent.

2. Description of the Prior Art

After the reaction between the component to be estimated and the added component(s), the enzyme activity of the final reaction mixture, or a certain fraction thereof, is measured, and this enzyme activity is a measure of the quantity of the component to be estimated. A larger number of variations on this immunological test method, and use of different techniques, are known. A possible way of performing the test for the demonstration of an antigen, for example HCG for the demonstration of pregnancy, consists of incubating a urine sample with a certain quantity of a coupling-product of HCG and an enzyme, and a certain quantity of an antibody against HCG, which has been rendered insoluble or may afterwards be rendered insoluble. A competitive reaction takes place between antibody and the HCG to be demonstrated on the one hand and between antibody and HCG coupled to enzyme on the other hand. After the immunochemical reaction has ceased, the enzyme activity in the solid or liquid phase of the reaction product finally obtained is measured, the said activity being a measure of the HCG to be estimated.

Use is preferably made of a peroxidase as enzyme-label in this enzyme immunotest, one of the reasons being that the activity of such an enzyme may be readily determined by colourimetric means, which means that the estimation in qualitative determinations may occur visually.

Test combinations which are marketed for the performance of enzyme immunotests therefore contain as an essential constituent a certain amount of an immunological component coupled to a peroxidase, whereby the reagents are preferably provided in a lyophilized state. As noted above, the major disadvantage of peroxidases is however that their qualities in low concentrations, either in dissolved or suspended state, are not kept over any substantial period of time. The peroxidase activity may also decrease during, or as a result of, freeze-drying. For these reasons, the attractiveness of the use of peroxidases is nullified.

SUMMARY OF THE INVENTION

It has surprisingly now been found that the stability of compositions containing peroxidase, whether or not lyophilized, can be substantially increased by the addition of polyvalent metal ions to the composition.

DESCRIPTION OF THE PREFERRED EMBODIMENTS

All polyvalent metal ions may be used but suitable polyvalent ions are particularly those ions of groups 3 and 4 of the Periodic Table, to wit Mg, Ca, Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, and Al. Preferable polyvalent ions include Al, Zn, Mg, Fe, and Cu, and most preferably Fe ions are used, particularly ferrous ions, since these exhibit in general a greater stabilizing effect than other metal ions.

The metal ions are usually added to the composition in the form of the appropriate metal salts, such as sulphates, phosphates, halides or nitrates.

The minimum amount of metal derivatives necessary for obtaining a stabilizing effect is 0.0001 M. The maximum quantity is not subject to strict limits, but optimal stability is generally achieved by the addition of 0.05 M, so that further addition is acceptable but unnecessary and extravagant. The quantity of peroxidase present in the aqueous medium to which the above-noted amount of metal derivative is added is between 1 nanogram and 25 micrograms per milliliter, and is generally between 10 nanograms and 10 micrograms.

It is recommendable that a suitable sequestering agent also be added to the composition, in order to prevent interference of the metal ions with the immunological estimation which will later be performed. Surprisingly, addition of a sequestering agent has no detrimental effect on the stabilizing ability of the metal ions. As examples of suitable sequestering agents are mentioned: ethylene diamine tetra-acetic acid (EDTA), citric acid, tartaric acid, glucuronic acid, saccharic acid, and suitable salts of these acids.

In addition to the above-noted components, other constituents may also be added to the composition, such as a buffer, sugars, for example sucrose, sorbitol or mannitol, a polyethylene glycol and/or proteins, such as albumin.

The aqueous peroxidase-containing compositions, to which a stabilizing amount of metal ions and optionally other components have been added, may be marketed as such, though they are usually first lyophilized.

Freeze-drying of the aqueous peroxidase-containing compositions takes place in the usual way by freezing at -40° C. to -50° C. and sublimation of the ice under reduced pressure.

Prior to the sublimation, the aqueous composition may also be brought into the form of granules by spraying into the air, or by allowing droplets of the aqueous composition to fall into a liquid which is not miscible with water and which is, either throughout or in part, at a temperature below the freezing point of the aqueous composition. The advantage of this latter possibility is that freeze-dried granules are obtained, containing previously determined and accurately measured quantities of reagents.

The following table indicates the result of the stabilizing influence of a number of metal ions, added to a peroxidase preparation; the numbers represent the time in weeks after which more than 80% of the original enzyme activity can still be detected.

    ______________________________________                                                          Temperature, °C.                                       Metal ion concentration                                                                               4        25    37                                       ______________________________________                                         Control   --            8       2     1                                        Al.sub.2 (SO.sub.4).sub.3                                                                0.01         16       16    10                                       MgSO.sub.4                                                                               0.01         16       2     1                                        ZnCl.sub.2                                                                               0.01         16       2     1                                        FeSO.sub.4                                                                               0.01         20       20    20                                       ______________________________________                                    

The following examples give a number of compositions which serve to further illustrate the invention.

EXAMPLE I

A preparation containing horse radish peroxidase (HRP-RZ 0.6) and albumin (BSA) in a ratio of 1:10 was dissolved in the following buffers:

(a) 0.02 M phosphate buffer, pH 6.0, 0.1% lactalbumin, 2.5% mannitol and 10⁻⁴ M FeSO₄.

(b) As (a), but omitting FeSO₄.

The content of HRP in both solutions was 12 ng/ml. The solutions were freeze-dried in vials.

The peroxidase activities of the products were determined immediately after freeze-drying; the enzyme activity in product (a) was unchanged, while product (b) possessed only 38% of the original enzyme activity.

EXAMPLE II

Horse radish peroxidase (RZ 0.6) was dissolved (8 μg/ml) in the following buffers:

(a) 0.01 M HEPES pH 8.0, 2% sucrose, 6% mannitol and 0.01 M FeSO₄.

(b) As (a) but omitting FeSO₄.

In both cases, droplets of about 50 μl were collected in liquid nitrogen, after which they were freeze-dried and kept at room temperature.

After 52 weeks, 80% of the original peroxidase activity was still present in product (a), while product (b) possessed only 17% of the original activity.

EXAMPLE III

A product obtained by coupling oestradiol and cytochrome c peroxidase was taken up in the following buffers:

(a) 0.36 M HEPES, 2% sucrose, 6% mannitol, 0.01 M EDTA and 0.01 M FeSO₄ (pH 7.4)

(b) As (a), but omitting FeSO₄.

The solutions were freeze-dried and kept at 37° C.

The peroxidase content was 270 ng/ml.

After 16 weeks, the enzyme activity of product (a) was practically unchanged, and the behaviour in an enzyme immunotest was the same as that of the original conjugate, while the enzyme activity of product (b) had fallen to less than 50% of the original activity.

EXAMPLE IV

A product obtained by coupling oestriol and horse radish peroxidase was dissolved in the following media:

(a) 0.01 M HEPES, 0.01 M EDTA, 2% sucrose and 0.01 M Al₂ (SO₄)₃.

(b) As (a), but omitting Al₂ (SO₄)₃.

The peroxidase content of both solutions was 180 ng/ml.

Both solutions were freeze-dried in droplet form as described in example II and were then kept at 37° C.

After 11 weeks, the peroxidase activity of product (a) was unchanged, while the enzyme activity of product (b) had already disappeared after a few days.

EXAMPLE V

In a way corresponding to that described in example III, a product obtained by coupling human placental lactogen (HPL) and horse radish peroxidase (HRP-RZ 0.6) was dissolved, freeze-dried and stored.

Product (a): after 22 weeks, 94% enzyme activity.

Product (b): after 22 weeks, no enzyme activity.

Analogous results were obtained with a product obtained by coupling anti-hepatitis B antibodies and horse radish peroxidase, but replacing the FeSO₄ in solution (a) by MgSO₄ as stabilizer, and with a product obtained by coupling sheep antibodies against human immunoglobulin and cytochrome c peroxidase, but using ZnCl₂ as the stabilizer in solution (a). 

What is claimed is:
 1. A method of manufacturing a composition useful as a diagnostic tool for enzyme immunoassay, comprising:(a) freezing at a temperature from about -40 Deg. F. to about -50 Deg. F. an aqueous peroxidase composition containing (1) peroxidase in an amount from about 1 nanogram per milliliter to about 25 micrograms per milliliter, and (2) at least one polyvalent metal salt selected from the group consisting of the sulphate, the phosphate, the halide, and nitrate of any of Mg, Ca, Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Ar, Zn, Ga, and Al present in a peroxidase-stabilizing amount of from about 0.0001 M to about 0.05 M to form a frozen ice; and (b) subliming said frozen ice under reduced pressure to form a freeze-dried composition.
 2. The method according to claim 1, in which the aqueous composition further contains a sequestering agent.
 3. The method according to claim 2, in which the sequestering agent is selected from the group consisting of ethylene diamine tetra-acetic acid (EDTA), citric acid, tartaric acid, glucuronic acid, saccharic acid, and suitable salts of these acids.
 4. The method according to claim 1 or claim 2, in which the aqueous composition further contains one or more ingredients selected from the group consisting of a buffer, polyethylene glycol, albumin, and a sugar.
 5. The method according to claim 4, in which the sugar is selected from the group consisting of sucrose, sorbitol and mannitol.
 6. The freeze-dried composition of claim
 1. 7. A method of manufacturing a composition useful as a diagnostic tool for enzyme immunoassay, comprising:(a) freezing at a temperature from about -40 Deg. F. to about -50 Deg. F. an aqueous peroxidase composition consisting essentially of (1) peroxidase in an amount from about 1 nanogram per milliliter to about 25 micrograms per milliliter, and (2) at least one polyvalent metal salt selected from the group consisting of the sulphate, the phosphate, the halide, and nitrate of any of Mg, Ca, Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Ar, Zn, Ga, and Al present in a peroxidase-stabilizing amount of from about 0.0001 M to about 0.05 M to form a frozen ice; and (b) subliming said frozen ice under reduced pressure to form a freeze-dried composition.
 8. The method according to claim 7, in which the aqueous composition further contains a sequestering agent.
 9. The method according to claim 8, in which the sequestering agent is selected from the group consisting of ethylene diamine tetra-acetic acid (EDTA), citric acid, tartaric acid, glucuronic acid, saccharic acid, and suitable salts of these acids.
 10. The method according to claim 7 or claim 9, in which the aqueous composition further contains one or more ingredients selected from the group consisting of buffer, polyethylene glycol, albumin, and a sugar.
 11. The method according to claim 10, in which the sugar is selected from the group selected from sucrose, sorbitol and mannitol.
 12. The freeze-dried composition of claim
 7. 